| + |
bortezomib | down-regulates activity
chemical inhibition
|
PSMB5 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-257820 |
|
|
Homo sapiens |
HeLa Cell |
| pmid |
sentence |
| 19428245 |
MG-132, which was one of the first synthetic inhibitors, interacts reversibly with the N-terminal threonine residue of the β5 active site. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
ixazomib | down-regulates
chemical inhibition
|
PSMB5 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-194509 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| Other |
|
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
ixazomib citrate | down-regulates
chemical inhibition
|
PSMB5 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-194536 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| Other |
|
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
carfilzomib | down-regulates activity
chemical inhibition
|
PSMB5 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-257818 |
|
|
Homo sapiens |
MOLT-4 Cell |
| pmid |
sentence |
| 19348473 |
Carfilzomib selectively inhibits the CT-L activity of the 20S proteasome and displays equivalent potency against β5 and LMP7 with minimal cross reactivity to other protease classes. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
PSMB5 | form complex
binding
|
26S Proteasome |
0.859 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-263357 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 29636472 |
Here, we report near-atomic resolution cryo-EM structures of the activated human proteasome|The proteasome is composed of a 28-subunit barrel-shaped core particle (CP) and two 19- subunit regulatory particles (RP)5–8 capped at both sides of the CP|Human proteasomes were purified through affinity chromatography on a large scale from a stable HEK293 cell line |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |